Diabetes Digest - DiabetesontheNet

This site is intended for healthcare professionals only

Diabetes Digest

New kids on the block: Friend or Foe?

Amid accumulating evidence of benefits with new diabetes drugs, Vinod Patel asks whether the costs can be justified.

Latest content

Tirzepatide reduces the predicted risk of developing type 2 diabetes

Predicted relative risk of type 2 diabetes reduced by about half at 24 weeks and by about two-thirds at 72 weeks.

Efficacy and safety of once-weekly insulins: Meta-analysis

Once-weekly insulins offer similar or superior glycaemic control to daily insulins, albeit with some greater weight gain.

Effects of canagliflozin are consistent across BMI classes

Cardiovascular and renal outcomes are similar in people with type 2 diabetes irrespective of BMI category.

Benefits and adverse events of newer diabetes therapies according to frailty status

SGLT2 inhibitors and GLP-1 RAs superior to DPP-4 inhibitors even in people with high frailty scores.

Ideas for diabetes care: Something borrowed, something blue

How does the old wedding tradition relate to best practice in diabetes care? Vinod Patel reveals all!

Sustained increase in physical fitness improves cardiometabolic risk independently of weight change

Sustained increase in physical fitness improves cardiometabolic risk independently of weight change.

Weight change and risk of 13 obesity-related complications

Benefits on 13 obesity-related complications are dependent on both magnitude of weight change and initial BMI.

Sleep quality as well as duration is associated with type 2 diabetes risk

Self-reported sleep quality is associated with type 2 diabetes risk, while sleep duration shows a U-shaped association.

Real-world data shows benefits of newer type 2 diabetes therapies

SGLT2 inhibitors and GLP-1 RAs are most effective at preventing cardiorenal outcomes, with greater effects when combined.

Vitamin D supplementation and chance of regression from prediabetes to normal glucose regulation

Vitamin D supplementation reduces risk of progression in people with prediabetes, but adherence is important.

What is health? The importance of patient-centred outcomes

Vinod Patel considers what defines health, what matters to our patients with type 2 diabetes and how to promote this.

Effects of novel glucose-lowering therapies on physical function

A potential benefit of newer diabetes therapies, particularly GLP-1 RAs, in improving physical function in people with type 2 diabetes.

Latest events & on-demand videos

2023: 16th Scottish Conference of the Primary Care Diabetes Society

DoubleTree by Hilton, Glasgow Central

Watch on demand!

2023: 13th Northern Ireland Conference of the Primary Care Diabetes Society

Hilton Belfast Templepatrick

Watch on demand!

2023: 16th All Ireland Conference of the Primary Care Diabetes Society

Crowne Plaza Dublin Airport

Presentations now available to view and download!

2022: 15th Scottish Conference of the Primary Care Diabetes Society – On-Demand

DoubleTree by Hilton, Glasgow Central

Now available on-demand!

2022: 12th Northern Ireland Conference of the Primary Care Diabetes Society

Hilton Templepatrick, Belfast

15 September 2022

Watch now on demand!

Previous

Next

Latest articles

New kids on the block: Friend or Foe?

Tirzepatide reduces the predicted risk of developing type 2 diabetes

Efficacy and safety of once-weekly insulins: Meta-analysis

Effects of canagliflozin are consistent across BMI classes

Benefits and adverse events of newer diabetes therapies according to frailty status

Ideas for diabetes care: Something borrowed, something blue

Sustained increase in physical fitness improves cardiometabolic risk independently of weight change

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;